Leading Edge Biotechnology to Enhance Organs for Cryonics, Space and Transplants

George Church describes the leading edge of biotechnology. He described antiaging and gene reading and writing capabilities. George Church Described Other Leading Edge Biotechnology They are closer to making organoids in days and they are vascularized. Having veins will enable larger organs. They have the worlds first complete human transcription library. They can use the …

Read moreLeading Edge Biotechnology to Enhance Organs for Cryonics, Space and Transplants

Alzheimer’s Drugs Reverse Broader Aging

In mouse models of Alzheimer’s disease, the drug candidates (CMS121 and J147) improve memory and slow the degeneration of brain cells. Researchers have shown how these compounds can also slow aging in healthy older mice, blocking the damage to brain cells that normally occurs during aging and restoring the levels of specific molecules to those …

Read moreAlzheimer’s Drugs Reverse Broader Aging

Blood Test Detects Rate of Brain Cell Death from Alzheimer’s Up to 16 Years Before Signs of Dementia

Scientists at the German Center for Neurodegenerative Diseases (DZNE), the Hertie Institute for Clinical Brain Research (HIH) and the University Hospital Tübingen now show that a protein found in the blood can be used to precisely monitor disease progression long before first clinical signs appear. When brain cells die, their remains can be detected in …

Read moreBlood Test Detects Rate of Brain Cell Death from Alzheimer’s Up to 16 Years Before Signs of Dementia

Samumed worth $12 billion is working on tissue regeneration to combat alzheimers and more

Samumed has raised $438 million with a $12 billion valuation. Samumed is a leader in medical research and development for tissue-level regeneration. They have a biotechnology platform based on small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology. One of the primary signaling pathways that …

Read moreSamumed worth $12 billion is working on tissue regeneration to combat alzheimers and more

United Neuroscience using endobody vaccines against Alzheimers

United Neuroscience (UNS) endobody vaccines train the body to develop its own defense against agents of chronic disease. Vaccines have been one of the most effective and impactful medicines in history. Vaccines historically target exogenous pathogens outside the body associated with infectious diseases, and there are now over a dozen infectious diseases that are preventable …

Read moreUnited Neuroscience using endobody vaccines against Alzheimers

Gene APOE4 causes Alzheimers disease in humans and a fix has been created

Researchers have found differences in how Alzheimers disease originates and develops in mice and humans. They determined which gene causes Alzheimers in humans and have developed a fix for it. Dementia and Alzheimer’s disease aren’t the same. Dementia is an overall term used to describe symptoms that impact memory, performance of daily activities, and communication …

Read moreGene APOE4 causes Alzheimers disease in humans and a fix has been created

Recording memory patterns and feeding back can boost memory by up to 37% in Alzheimers patients

Scientists at Wake Forest Baptist Medical Center and the University of Southern California (USC) have demonstrated the successful implementation of a prosthetic system that uses a person’s own memory patterns to facilitate the brain’s ability to encode and recall memory. Advanced Lifelogging seems needed to support memory boosting. Most Healthy early lifelogging adopters found it …

Read moreRecording memory patterns and feeding back can boost memory by up to 37% in Alzheimers patients

Bill Gates believes Alzheimers research is a turning point and is investing $100 million to accelerate progress

Bill Gates has personally invested $50 million in the Dementia Discovery Fund—a private fund working to diversify the clinical pipeline and identify new targets for treatment. Most of the major pharmaceutical companies continue to pursue the amyloid and tau pathways. DDF complements their work by supporting startups as they explore less mainstream approaches to treating …

Read moreBill Gates believes Alzheimers research is a turning point and is investing $100 million to accelerate progress

Success against Alzheimers and Dementia in mice

Scientists from the Technical University of Munich has used a BACE inhibitor drug reduces the amount of amyloid beta in the brains of mice and restores the normal function of nerve cells and significantly improves memory. Around 50 million people worldwide suffer from dementia. To date, no effective drug is available that is able to …

Read moreSuccess against Alzheimers and Dementia in mice

DARPA seeks drone escort for military truck convoys to protect against enemy drones

DARPA is asking for industry’s help in developing a agile and mobile drone-defense system that can defeat a raid of self-guided, small unmanned aerial systems (UAS) that are attacking an important moving target like a high-value convoy. The potential $63 million Mobile force protection project seeks ways to defend against not only today’s radio-controlled and …

Read moreDARPA seeks drone escort for military truck convoys to protect against enemy drones